Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SHANGHAI PECHEM
00338
5
SINOPEC CORP
00386
| (FY)Dec 31, 2025 | (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | -111.75%-4.81M | ---- | -2.38%40.97M | ---- | -11.52%41.97M | ---- | -0.90%47.44M | ---- | 47.08%47.87M | ---- |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | 4.71%-1.25M | ---- | -6.56%-1.32M | ---- | -281.17%-1.24M | ---- | -21.80%-324K | ---- | -86.01%-266K | ---- |
| Interest expense - adjustment | -27.34%186K | ---- | 21.33%256K | ---- | 28.66%211K | ---- | -15.90%164K | ---- | -8.02%195K | ---- |
| Impairment and provisions: | -73.88%1.04M | ---- | 86.01%3.96M | ---- | --2.13M | ---- | ---- | ---- | ---- | ---- |
| -Impairment of property, plant and equipment (reversal) | -73.88%1.04M | ---- | 86.01%3.96M | ---- | --2.13M | ---- | ---- | ---- | ---- | ---- |
| Revaluation surplus: | 28.68%5.42M | ---- | 344.46%4.21M | ---- | --947K | ---- | ---- | ---- | ---- | ---- |
| -Other fair value changes | 28.68%5.42M | ---- | 344.46%4.21M | ---- | --947K | ---- | ---- | ---- | ---- | ---- |
| Asset sale loss (gain): | 338.15%1.18M | ---- | --270K | ---- | ---- | ---- | 95.48%303K | ---- | 573.91%155K | ---- |
| -Loss (gain) on sale of property, machinery and equipment | 338.15%1.18M | ---- | --270K | ---- | ---- | ---- | 95.48%303K | ---- | 573.91%155K | ---- |
| Depreciation and amortization: | -13.10%13.68M | ---- | -10.14%15.74M | ---- | 10.76%17.52M | ---- | 32.50%15.82M | ---- | 30.08%11.94M | ---- |
| -Amortization of intangible assets | -44.37%1.45M | ---- | -25.79%2.61M | ---- | -3.43%3.52M | ---- | 82.10%3.64M | ---- | 0.00%2M | ---- |
| Operating profit before the change of operating capital | -75.92%15.43M | ---- | 4.15%64.1M | ---- | -2.92%61.54M | ---- | 5.85%63.4M | ---- | 43.22%59.89M | ---- |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | 993.65%4.08M | ---- | 17.51%-457K | ---- | 33.17%-554K | ---- | -1,459.02%-829K | ---- | 106.51%61K | ---- |
| Accounts receivable (increase)decrease | 5,900.00%30.74M | ---- | -116.49%-530K | ---- | 117.59%3.22M | ---- | -291.79%-18.28M | ---- | -168.13%-4.67M | ---- |
| Accounts payable increase (decrease) | -2,121.32%-27.59M | ---- | -43.97%1.37M | ---- | -26.89%2.44M | ---- | 100.60%3.33M | ---- | 279.76%1.66M | ---- |
| Cash from business operations | -64.85%22.67M | ---- | -3.25%64.47M | ---- | 39.94%66.64M | ---- | -16.38%47.62M | ---- | 21.68%56.95M | ---- |
| Other taxs | 62.60%-5.53M | ---- | -6.68%-14.78M | ---- | -4.45%-13.86M | ---- | -13.75%-13.27M | ---- | -1.51%-11.66M | ---- |
| Interest paid - operating | 27.34%-186K | ---- | -21.33%-256K | ---- | -28.66%-211K | ---- | 15.90%-164K | ---- | 8.02%-195K | ---- |
| Special items of business | ---- | 54.69%11.78M | ---- | -19.17%7.62M | ---- | -54.15%9.42M | ---- | 24.49%20.55M | ---- | 3.23%16.51M |
| Net cash from operations | -65.71%16.95M | 54.69%11.78M | -5.97%49.44M | -19.17%7.62M | 53.76%52.57M | -54.15%9.42M | -24.17%34.19M | 24.49%20.55M | 28.46%45.09M | 3.23%16.51M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | -4.71%1.25M | -39.35%94K | 6.56%1.32M | -8.82%155K | 281.17%1.24M | -3.41%170K | 21.80%324K | 44.26%176K | 86.01%266K | 144.00%122K |
| Sale of fixed assets | 2,572.41%1.55M | ---- | --58K | ---- | ---- | ---- | -13.64%133K | -66.67%27K | 129.85%154K | --81K |
| Purchase of fixed assets | -55.43%-12.07M | -2.74%-2.63M | -56.98%-7.77M | -6.59%-2.56M | 71.39%-4.95M | 83.89%-2.4M | -83.33%-17.29M | -292.04%-14.88M | 60.37%-9.43M | -3.80%-3.8M |
| Purchase of intangible assets | ---- | ---- | ---- | ---- | 89.09%-480K | ---- | ---4.4M | ---2.61M | ---- | ---- |
| Acquisition of subsidiaries | ---- | ---- | ---- | ---- | ---- | ---- | --29K | --29K | ---- | ---- |
| Net cash from investment operations | -44.98%-9.27M | -5.46%-2.53M | -52.48%-6.39M | -7.77%-2.4M | 80.23%-4.19M | 87.10%-2.23M | -135.31%-21.2M | -380.38%-17.26M | 61.80%-9.01M | 0.39%-3.59M |
| Net cash before financing | -82.15%7.68M | 77.34%9.25M | -11.03%43.04M | -27.50%5.22M | 272.53%48.38M | 118.59%7.2M | -64.00%12.99M | -74.51%3.29M | 213.39%36.08M | 4.28%12.92M |
| Cash flow from financing activities | ||||||||||
| Net cash from financing operations | -30.04%-2.87M | 9.31%-1.54M | -33.25%-2.2M | -97.79%-1.7M | -41.01%-1.65M | -45.42%-858K | -21.43%-1.17M | -101.37%-590K | -102.82%-966K | ---293K |
| Effect of rate | -103.85%-2K | -61.11%7K | 213.04%52K | 114.63%18K | 94.77%-46K | 61.44%-123K | -776.92%-880K | -4,087.50%-319K | -73.14%130K | 0.00%8K |
| Net Cash | -88.20%4.82M | 119.12%7.71M | -12.60%40.84M | -44.46%3.52M | 295.51%46.73M | 134.57%6.34M | -66.35%11.81M | -78.59%2.7M | -23.24%35.11M | 1.91%12.62M |
| Begining period cash | 24.74%206.14M | 24.74%206.14M | 39.37%165.25M | 39.37%165.25M | 10.16%118.57M | 10.16%118.57M | 48.68%107.64M | 48.68%107.64M | 176.63%72.4M | 176.63%72.4M |
| Cash at the end | 2.34%210.96M | 26.70%213.86M | 24.74%206.14M | 35.26%168.79M | 39.37%165.25M | 13.42%124.79M | 10.16%118.57M | 29.40%110.02M | 48.68%107.64M | 120.48%85.03M |
| Cash balance analysis | ||||||||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- |
| Auditor | Grant Thornton (Hong Kong) Limited | -- | Grant Thornton (Hong Kong) Limited | -- | Grant Thornton (Hong Kong) Limited | -- | Grant Thornton (Hong Kong) Limited | -- | Grant Thornton (Hong Kong) Limited | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.